What is Mutamycin ?

Mitomycin is an antineoplastic antibiotic that inhibits DNA synthesis, primarily used in the treatment of various cancers, including stomach and pancreatic cancer. Its mechanism of action involves cross-linking DNA strands, thereby preventing cancer cell replication and leading to cell death. Administered intravenously, Mitomycin is often used in combination with other chemotherapeutic agents for enhanced efficacy.

• Nausea
• Vomiting
• Diarrhea
• Mouth sores
• Fatigue
• Loss of appetite
• Skin rash
• Hair loss
• Cough or shortness of breath
• Easy bruising or bleeding

• Bone marrow suppression leading to decreased blood cell counts
• Risk of serious or fatal lung problems
• Severe skin reactions at the site of injection
• Potential risk of kidney damage
• Use caution in patients with renal impairment
• May cause secondary malignancies
• Not recommended during pregnancy due to potential harm to the fetus
• Patients should be monitored for signs of infection due to immune suppression
• Avoid use in patients with a history of hypersensitivity to mitomycin
• Regular monitoring of blood counts is necessary